GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
GlaxoSmithKline plc (GSK or 'the company') is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, Benlysta SCbelimumab, Benlysta, Augmentin, FluLaval, Bexsero, Menveo, Zovirax, Pronamel, Otrivin, Theraflu, Aquafresh, Abreva and Poligrip brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, Australasia, and Europe. The company is headquartered in Brentford, Middlesex, the UK.
Key Highlights
GlaxoSmithKline plc (GSK or 'the company') is a developer, manufacturer, and marketer of vaccines, pharmaceuticals, over-the-counter (OTC) medicines and consumer healthcare products. The company offers medicines for various therapeutic areas, including respiratory, HIV, metabolic, anti-virals, urogenital, central nervous system, immuno-inflammation, cardiovascular, anti-bacterials and dermatology. GSK markets its products under Volibris, Benlysta SCbelimumab, Benlysta, Augmentin, FluLaval, Bexsero, Menveo, Zovirax, Pronamel, Otrivin, Theraflu, Aquafresh, Abreva and Poligrip brand names. It merchandises and sells these products through pharmacies, hospitals, wholesalers, and physicians worldwide. GSK has a business presence across the Americas, the Middle East, Africa, Australasia, and Europe. The company is headquartered in Brentford, Middlesex, the UK.
Scope
- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
- Intelligence on GlaxoSmithKline Plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.
Table of Contents
Company Snapshot
Appendix
List of Tables
List of Figures
